Synairgen plc (LON:SNG – Get Free Report)’s stock price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 5.45 ($0.07) and traded as high as GBX 7.35 ($0.09). Synairgen shares last traded at GBX 7.02 ($0.09), with a volume of 30,405 shares traded.
Synairgen Stock Performance
The company has a debt-to-equity ratio of 0.09, a current ratio of 6.77 and a quick ratio of 6.35. The company has a fifty day moving average of GBX 5.45 and a two-hundred day moving average of GBX 6.19. The stock has a market capitalization of £13.37 million, a P/E ratio of -140.40 and a beta of -2.23.
Synairgen Company Profile
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
See Also
- Five stocks we like better than Synairgen
- Insider Trading – What You Need to Know
- Charles Schwab Fortifies its Uptrend on EPS Beat
- How to Invest in the FAANG Stocks
- Lockheed Martin Stock Aims for a Fresh All-Time High
- What is the Euro STOXX 50 Index?
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.